A Comparison Of Major American MSO Cannabis Stocks' Q3 Metrics
Over the past 2 weeks the 12 constituents in the munKNEE American Cannabis MSO Stocks Index have announced their third quarter (Q3) financial results and their results are compared below, as well as the extent to which each company might encounter financial distress in the next 2 years compared to its peers as sourced from macroaxis.com. It is clearly evident that Green Thumb Holdings Inc. is head and shoulders above its peers in the category.
- Green Thumb (GTBIF):
- Revenue Growth (UP/DOWN): UP
- Gross Profit (UP/DOWN): UP
- Net Operating Cash Flow (Positive/Negative): Yes (Source)
- EBITDA (Positive/Negative): Positive
- EBITDA Growth (Yes/No): Yes (Source)
- EBITDA Margin (%): 38.0%
- Net Profit/Loss (Positive/Negative): Positive
- Net Profit/Loss Growth (Yes/No): Yes
- Chance of Financial Distress (%): 14% (Source)
- Read: Green Thumb Q3 Reports Record Revenue
The remaining 11 constituents:
- ALL showed a positive Adjusted EBITDA
- but NONE showed any improvement in the quarter and
- ALL showed a negative Net Profit
- and NONE showed any improvement in the quarter.
The differences in their Q3 performances were in:
- Revenue growth,
- Gross Profit growth and in their
- Adj. EBITDA Margins
as depicted below in descending order based on the latter, as follows:
- Ayr (AYRWF):
- Revenue Growth (UP/DOWN): UP
- Gross Profit (UP/DOWN): UP
- Adj. EBITDA Growth (Yes/No): Yes
- Adj. EBITDA Margin (%): 202%s
- Chance of Financial Distress (%): 73%
- Read: Ayr Wellness Q3 Financial Metrics All Show Major Improvement
- Trulieve (TCNNF):
- Revenue Growth (UP/DOWN): DOWN
- Gross Profit (UP/DOWN): DOWN
- Adj. EBITDA Growth (Yes/No): No
- Adj. EBITDA Margin (%): 28.1%
- Chance of Financial Distress (%): 74%
- Read: Trulieve Cannabis Q3 Financials Were Down But Stock Price Jumps
- Cresco (CRLBF):
- Revenue Growth (UP/DOWN): DOWN
- Gross Profit (UP/DOWN): DOWN
- Adj. EBITDA Growth (Yes/No): No
- Adj. EBITDA Margin (%): 18.0%
- Chance of Financial Distress (%): 74%
- Read: Cresco Labs Q3 Financials Show No Improvement Over Q2 Results
- Verano (VRNOF):
- Revenue Growth (UP/DOWN): UP
- Gross Profit (UP/DOWN): UP
- Adj. EBITDA Growth (Yes/No): Yes
- Adj. EBITDA Margin (%): 14.9%
- Chance of Financial Distress (%): 70%
- Read: Verano Q3 Financial Report Reveals Major Increase In Net Loss
- TerrAscend (TRSSF):
- Revenue Growth (UP/DOWN): UP
- Gross Profit (UP/DOWN): UP
- Adj. EBITDA Growth (Yes/No): No
- Adj. EBITDA Margin (%): 13.5%
- Chance of Financial Distress (%): 74%
- Read: TerrAscend Q3 Financial Report Reveals Major Declines In Income And EBITDA
- Acreage (ACRDF):
- Revenue Growth (UP/DOWN): UP
- Gross Profit (UP/DOWN): UP
- Adj. EBITDA Growth (Yes/No): No
- Adj. EBITDA Margin (%): 13.5%
- Chance of Financial Distress (%): 73%
- Read: Acreage Reports Third Quarter 2022 Financial Results
- Ascend (AAWH):
- Revenue Growth (UP/DOWN): UP
- Gross Profit (UP/DOWN): UP
- Adj. EBITDA Growth (Yes/No): Yes
- Adj. EBITDA Margin (%): 8.3%
- Chance of Financial Distress (%): 77%
- Read: Ascend Wellness Q3 Report: Record Revenue, Adjusted Gross Profit And EBITDA Margin
- Planet 13 (PLNHF):
- Revenue Growth (UP/DOWN): DOWN
- Gross Profit (UP/DOWN): DOWN
- Adj. EBITDA Growth (Yes/No): No
- Adj. EBITDA Margin (%): 3.0%
- Chance of Financial Distress (%): 36%
- Read: Planet 13 Financial Metrics In Q3 All Declined
- Columbia Care (CCHWF):
- Revenue Growth (UP/DOWN): UP
- Gross Profit (UP/DOWN): UP
- Adj. EBITDA Growth (Yes/No): No
- Adj. EBITDA Margin (%): -1.6%
- Chance of Financial Distress (%): 73%
- Read: Columbia Care Reports Third Quarter 2022 Results
- Jushi (JUSHF):
- Revenue Growth (UP/DOWN): No Change
- Gross Profit (UP/DOWN): UP
- Adj. EBITDA Growth (Yes/No): No Change
- Adj. EBITDA Margin (%): -7.2%
- Chance of Financial Distress (%): 77%
- Read: Jushi Holdings Releases Mixed Preliminary Q3 Financials
- Curaleaf (CURLF):
- Revenue Growth (UP/DOWN): UP
- Gross Profit (UP/DOWN): DOWN
- Adj. EBITDA Growth (Yes/No): No
- Adj. EBITDA Margin (%): -14.6%
- Chance of Financial Distress (%): 73%
- Read: Curaleaf Q3 Report Reveals +80% Decrease In Net Profit
More By This Author:
TerrAscend Q3 Financial Report Reveals Major Declines In Income And EBITDA
Verano Q3 Financial Report Reveals Major Increase In Net Loss
Trulieve Cannabis Q3 Financials Were Down But Stock Price Jumps
Visit munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample more